This hub covers epilepsy and pregnancy: Seizure control, medication safety, folic acid, and planning before, during, and after pregnancy. Research summaries to support informed decisions.
No. Stopping medication suddenly can be dangerous. Medication decisions should be planned with your neurologist/OB.
Body water, metabolism, and clearance change. Some meds need dose adjustments guided by blood levels.
Not always. Many people remain stable, especially with good adherence and monitoring.
Sleep deprivation is a real risk. Planning shifts and extra support isn’t “extra,” it’s safety.
A recent study looked at how anti-seizure medications (ASMs) are used and their costs for children in France from 2014 to 2023.
Researchers studied the effects of stopping or switching valproic acid (VPA) in women with epilepsy who were planning to become pregnant or were already pregnant.
Researchers studied the effects of valproate (VPA), a medication used to treat epilepsy, on pregnant women and their babies.
Researchers studied how sex and gender differences affect various neurological diseases, including epilepsy, in both men and women.
Researchers studied a genetic condition called PPP2R1A-related neurodevelopmental disorders, which can lead to developmental delays, intellectual disabilities, epilepsy, and brain malformations.
This study looked at how taking antiseizure medications (ASMs) during pregnancy affects the risk of birth defects in babies.
This study looked at different methods used to create consensus-based recommendations (CBRs) for epilepsy care.
This study looked at how being exposed to antiseizure medications (ASMs) before birth affects children’s cognitive development from ages 2 to 6.
A study was conducted in Brazil to understand the relationship between prenatal exposure to the Zika virus and the risk of epilepsy-related hospitalizations in young children.